191 related articles for article (PubMed ID: 36325743)
1. An independent Monte Carlo-based IMRT QA tool for a 0.35 T MRI-guided linear accelerator.
Khan AU; Simiele EA; Lotey R; DeWerd LA; Yadav P
J Appl Clin Med Phys; 2023 Feb; 24(2):e13820. PubMed ID: 36325743
[TBL] [Abstract][Full Text] [Related]
2. A clinical validation of the MR-compatible Delta
Desai V; Bayouth J; Smilowitz J; Yadav P
J Appl Clin Med Phys; 2021 Apr; 22(4):82-91. PubMed ID: 33666360
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo based IMRT dose verification using MLC log files and R/V outputs.
Luo W; Li J; Price RA; Chen L; Yang J; Fan J; Chen Z; McNeeley S; Xu X; Ma CM
Med Phys; 2006 Jul; 33(7):2557-64. PubMed ID: 16898460
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of machine log files/MC-based treatment planning and delivery QA as compared to ArcCHECK QA.
Stanhope CW; Drake DG; Liang J; Alber M; Söhn M; Habib C; Willcut V; Yan D
Med Phys; 2018 Jul; 45(7):2864-2874. PubMed ID: 29676463
[TBL] [Abstract][Full Text] [Related]
5. A structured FMEA approach to optimizing combinations of plan-specific quality assurance techniques for IMRT and VMAT QA.
O'Daniel JC; Giles W; Cui Y; Adamson J
Med Phys; 2023 Sep; 50(9):5387-5397. PubMed ID: 37475493
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo simulation-based patient-specific QA using machine log files for line-scanning proton radiation therapy.
Jeon C; Lee J; Shin J; Cheon W; Ahn S; Jo K; Han Y
Med Phys; 2023 Nov; 50(11):7139-7153. PubMed ID: 37756652
[TBL] [Abstract][Full Text] [Related]
7. Development and clinical application of a GPU-based Monte Carlo dose verification module and software for 1.5 T MR-LINAC.
Cheng B; Xu Y; Li S; Ren Q; Pei X; Men K; Dai J; Xu XG
Med Phys; 2023 May; 50(5):3172-3183. PubMed ID: 36862110
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo investigation of collapsed versus rotated IMRT plan verification.
Conneely E; Alexander A; Ruo R; Chung E; Seuntjens J; Foley MJ
J Appl Clin Med Phys; 2014 May; 15(3):4681. PubMed ID: 24892340
[TBL] [Abstract][Full Text] [Related]
9. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
[TBL] [Abstract][Full Text] [Related]
10. Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.
Chan MF; Li J; Schupak K; Burman C
Technol Cancer Res Treat; 2014 Feb; 13(1):57-67. PubMed ID: 23819494
[TBL] [Abstract][Full Text] [Related]
11. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
12. Deep Learning for Patient-Specific Quality Assurance: Predicting Gamma Passing Rates for IMRT Based on Delivery Fluence Informed by log Files.
Huang Y; Pi Y; Ma K; Miao X; Fu S; Zhu Z; Cheng Y; Zhang Z; Chen H; Wang H; Gu H; Shao Y; Duan Y; Feng A; Zhuo W; Xu Z
Technol Cancer Res Treat; 2022; 21():15330338221104881. PubMed ID: 35726209
[No Abstract] [Full Text] [Related]
13. Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.
Agnew CE; Irvine DM; McGarry CK
J Appl Clin Med Phys; 2014 Nov; 15(6):4994. PubMed ID: 25493524
[TBL] [Abstract][Full Text] [Related]
14. Virtual patient-specific QA with DVH-based metrics.
Lay LM; Chuang KC; Wu Y; Giles W; Adamson J
J Appl Clin Med Phys; 2022 Nov; 23(11):e13639. PubMed ID: 35570395
[TBL] [Abstract][Full Text] [Related]
15. Characterization of positional accuracy of a double-focused and double-stack multileaf collimator on an MR-guided radiotherapy (MRgRT) Linac using an IC-profiler array.
Mittauer KE; Yadav P; Paliwal B; Bayouth JE
Med Phys; 2020 Feb; 47(2):317-330. PubMed ID: 31682018
[TBL] [Abstract][Full Text] [Related]
16. Efficient and reliable 3D dose quality assurance for IMRT by combining independent dose calculations with measurements.
Visser R; Wauben DJ; de Groot M; Godart J; Langendijk JA; van't Veld AA; Korevaar EW
Med Phys; 2013 Feb; 40(2):021710. PubMed ID: 23387733
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of a GATE Monte Carlo platform in a clinical pretreatment QA system for VMAT treatment plans using TrueBeam with an HD120 multileaf collimator.
Lee B; Jeong S; Chung K; Yoon M; Park HC; Han Y; Jung SH
J Appl Clin Med Phys; 2019 Oct; 20(10):101-110. PubMed ID: 31544350
[TBL] [Abstract][Full Text] [Related]
18. MOSFET dosimeter characterization in MR-guided radiation therapy (MRgRT) Linac.
Yadav P; Hallil A; Tewatia D; Dunkerley DAP; Paliwal B
J Appl Clin Med Phys; 2020 Jan; 21(1):127-135. PubMed ID: 31854078
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 4-Hz log files and secondary Monte Carlo dose calculation as patient-specific quality assurance for VMAT prostate plans.
Szeverinski P; Kowatsch M; Künzler T; Meinschad M; Clemens P; DeVries AF
J Appl Clin Med Phys; 2021 Jul; 22(7):235-244. PubMed ID: 34151502
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI-guided linear accelerator.
Graham JA; Redler G; Delozier KB; Yu HM; Oliver DE; Rosenberg SA
J Appl Clin Med Phys; 2022 Jun; 23(6):e13587. PubMed ID: 35344266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
